Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered T cell therapy for viral and non-viral epithelial cancers

Cancer Cell(2022)10.1016/j.ccell.2022.10.016Source: DataRank Database

Engineered T cell therapy for viral and non-viral epithelial cancers is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 0. It has been cited 97 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access97 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: greenTopics (34)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Christian S. Hinrichs ORCID,Scott M. Norberg ORCID

Live enrichment

PubMed:36400016

National Institutes of Health

Grant: 3P30CA072720-22S1

T-Cell Receptor Discovery for Engineered T-cell Therapy for Human Cancers

National Institutes of Health

Grant: PCT/US2014/046478

National Institutes of Health

Grant: PCT/US2015/033129

National Institutes of Health

Grant: PCT/US2017/027865

National Institutes of Health

Grant: PCT/US2018/031501

National Institutes of Health

Grant: PCT/US2019/016975

National Institutes of Health

Grant: PCT/US2021/059109

National Institutes of Health

Grant: PCT/US2021/38649

Cancer Moonshot

Grant: 011871-02

Cancer Moonshot

Grant: BC011871-02

NCI NIH HHS

Grant: P30 CA072720

Intramural NIH HHS

Grant: ZIA BC011479

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9839504

publisherhttps://api.elsevier.com/content/article/PII:S1535610822005074?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610822005074?httpAccept=text/plain

https://doi.org/10.1016/j.ccell.2022.10.016

https://pubmed.ncbi.nlm.nih.gov/36400016

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciencesHumansT-LymphocytesImmunotherapy, AdoptiveNeoplasmsReceptors, Antigen, T-CellLymphocytes, Tumor-Infiltrating

MeSH Terms

HumansT-LymphocytesImmunotherapy, AdoptiveNeoplasmsReceptors, Antigen, T-CellLymphocytes, Tumor-Infiltrating

Keywords

Lymphocytes, Tumor-InfiltratingT-LymphocytesNeoplasmsReceptors, Antigen, T-CellHumansImmunotherapy, AdoptiveCAR-T cellT cell receptorTCR-T cellTILadoptive cell transfercell therapycervical cancerchimeric antigen receptorepithelial cancergastric cancerhuman papillomavirusimmunotherapytumor-infiltrating lymphocytes

Sustainable Development Goals

SDG 3: 3. Good health